BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37923243)

  • 21. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.
    Gillmore JD; Maurer MS; Falk RH; Merlini G; Damy T; Dispenzieri A; Wechalekar AD; Berk JL; Quarta CC; Grogan M; Lachmann HJ; Bokhari S; Castano A; Dorbala S; Johnson GB; Glaudemans AW; Rezk T; Fontana M; Palladini G; Milani P; Guidalotti PL; Flatman K; Lane T; Vonberg FW; Whelan CJ; Moon JC; Ruberg FL; Miller EJ; Hutt DF; Hazenberg BP; Rapezzi C; Hawkins PN
    Circulation; 2016 Jun; 133(24):2404-12. PubMed ID: 27143678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
    Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. False-positive bone scintigraphy denoting transthyretin amyloid in elderly hypertrophic cardiomyopathy.
    Chimenti C; Alfarano M; Maestrini V; Galea N; De Vincentis G; Verardo R; Fedele F; Frustaci A
    ESC Heart Fail; 2021 Aug; 8(4):3387-3391. PubMed ID: 34032384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).
    Pilebro B; Arvidsson S; Lindqvist P; Sundström T; Westermark P; Antoni G; Suhr O; Sörensen J
    J Nucl Cardiol; 2018 Feb; 25(1):240-248. PubMed ID: 27645889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
    Chen W; Ton VK; Dilsizian V
    Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing
    Stassen J; van der Bijl P; Bax JJ
    J Nucl Cardiol; 2021 Dec; 28(6):2497-2499. PubMed ID: 34331216
    [No Abstract]   [Full Text] [Related]  

  • 27. Monitoring of cardiac transthyretin amyloid load by [
    Minutoli F; Laudicella R; Baldari S
    Amyloid; 2022 Sep; 29(3):210. PubMed ID: 35321592
    [No Abstract]   [Full Text] [Related]  

  • 28. Correlation of 99mTc-DPD bone scintigraphy with histological amyloid load in patients with ATTR cardiac amyloidosis.
    Ungericht M; Groaz V; Messner M; Schuetz T; Brunelli L; Zaruba MM; Lener D; Stocker E; Bauer A; Kroiss AS; Mayr A; Röcken C; Poelzl G
    Amyloid; 2024 Mar; 31(1):22-31. PubMed ID: 37530216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Phase
    Galat A; Van der Gucht A; Guellich A; Bodez D; Cottereau AS; Guendouz S; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T; Rosso J
    JACC Cardiovasc Imaging; 2017 May; 10(5):601-603. PubMed ID: 27424245
    [No Abstract]   [Full Text] [Related]  

  • 30. Low-sensitivity 99mTc pyrophosphate scintigraphy for hereditary transthyretin cardiac amyloidosis with Glu112Lys genotype.
    Deng Y; Pan R; Guo Y; Wang X; Tian Z
    Eur Heart J Cardiovasc Imaging; 2024 Feb; 25(3):e115. PubMed ID: 37956103
    [No Abstract]   [Full Text] [Related]  

  • 31. Quantification of cardiac amyloid with [
    Möckelind S; Axelsson J; Pilebro B; Lindqvist P; Suhr OB; Sundström T
    Amyloid; 2020 Sep; 27(3):191-199. PubMed ID: 32400202
    [No Abstract]   [Full Text] [Related]  

  • 32. The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease.
    Azevedo Coutinho MC; Cortez-Dias N; Cantinho G; Gonçalves S; Menezes MN; Guimarães T; Lima da Silva G; Francisco AR; Agostinho J; Santos L; Conceição I; Pinto FJ
    Amyloid; 2020 Sep; 27(3):174-183. PubMed ID: 32482106
    [No Abstract]   [Full Text] [Related]  

  • 33. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
    Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
    J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.
    Hutt DF; Fontana M; Burniston M; Quigley AM; Petrie A; Ross JC; Page J; Martinez-Naharro A; Wechalekar AD; Lachmann HJ; Quarta CC; Rezk T; Mahmood S; Sachchithanantham S; Youngstein T; Whelan CJ; Lane T; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD
    Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1344-1350. PubMed ID: 28159995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis.
    Singh V; Falk R; Di Carli MF; Kijewski M; Rapezzi C; Dorbala S
    J Nucl Cardiol; 2019 Feb; 26(1):158-173. PubMed ID: 30569412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can Nuclear Imaging Techniques Predict Patient Outcome and Guide Medical Management in Hereditary Transthyretin Cardiac Amyloidosis?
    Algalarrondo V; Piekarski E; Eliahou L; Le Guludec D; Slama MS; Rouzet F
    Curr Cardiol Rep; 2018 Mar; 20(5):33. PubMed ID: 29574587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.
    Pilebro B; Suhr OB; Näslund U; Westermark P; Lindqvist P; Sundström T
    Ups J Med Sci; 2016; 121(1):17-24. PubMed ID: 26849806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of Single-Photon Emission Computed Tomography/Computed Tomography Fusion Imaging With
    Tsuda N; Shiraishi S; Oda S; Ogasawara K; Sakamoto F; Tomiguchi S; Fujisue K; Takashio S; Izumiya Y; Tsujita K; Ando Y; Yamashita Y
    Circ J; 2018 Jun; 82(7):1970-1971. PubMed ID: 29199249
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers.
    Piekarski E; Chequer R; Algalarrondo V; Eliahou L; Mahida B; Vigne J; Adams D; Slama MS; Le Guludec D; Rouzet F
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1108-1118. PubMed ID: 29511839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of Bone-Tracer Uptake in Cardiac Transthyretin Amyloidosis.
    Groothof D; Nienhuis HLA; Bijzet J; Houwerzijl EJ; van den Berg MP; Glaudemans AWJM; Slart RHJA; Hazenberg BPC
    Mayo Clin Proc; 2020 Feb; 95(2):417-418. PubMed ID: 31883697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.